Gilberto Lopes, MD

Experts in cancer management share their final thoughts on effective treatment and individualized care vs financial toxicity.

A panel of experts debate the cost of innovation vs disruptive pricing of therapy.

Jack West, MD, and Gilberto Lopes, MD, share their thoughts on mitigating strategies of therapy associated with financial toxicity.

A panel of experts in cancer treatment review the need for PD-1/PD-L1 testing for immunotherapy.

Gilberto Lopes, MD, Jack West, MD, and Mark Socinski, MD, provide their insight on the pharmacoeconomic considerations for immunotherapy.

Experts in cancer care management review PD-1/PD-L1 immunotherapy for patients with NSCLC and GI cancers.

A panel of experts discuss treatment options based on efficacy and out-of-pocket cost for patients.

Gilberto Lopes, MD, a medical oncologist at the Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses findings from the KEYNOTE-042 trial of frontline pembrolizumab (Keytruda) as a treatment for patients with squamous and nonsquamous non–small cell lung cancer in an interview with OncLive during the 2018 ASCO Annual Meeting.